Speciality: Oncology
Description:
Welcome to today’s episode, where we explore immunotherapy—the innovative approach that’s transforming cancer treatment. Unlike traditional therapies such as chemotherapy and radiation, immunotherapy harnesses the power of your own immune system to identify and attack cancer cells. Treatments like checkpoint inhibitors and CAR T-cell therapy are showing promising results, offering new hope for patients with advanced or hard-to-treat cancers. While not every patient responds the same way, ongoing research is refining these therapies to improve effectiveness and reduce side effects. Immunotherapy marks a significant shift, paving the way for more personalised and targeted cancer care. Stay tuned as we continue to follow this exciting development in oncology.
See More Webinars @ Hidoc Webinars
1.
Datopotamab Deruxtecan Earns New Breast Cancer Indication
2.
Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.
3.
Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.
4.
The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.
5.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
1.
Engineered Red Blood Cell Therapeutics: Emerging Applications
2.
A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia
3.
AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined
4.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
5.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation